ID CMA1_HUMAN Reviewed; 247 AA. AC P23946; B5BUM8; Q16018; Q3SY36; Q3SY37; Q9UDH5; DT 01-MAR-1992, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-1992, sequence version 1. DT 24-JAN-2024, entry version 213. DE RecName: Full=Chymase; DE EC=3.4.21.39; DE AltName: Full=Alpha-chymase; DE AltName: Full=Mast cell protease I; DE Flags: Precursor; GN Name=CMA1; Synonyms=CYH, CYM; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=2071582; DOI=10.1016/s0021-9258(18)98788-0; RA Caughey G.H., Zerweck E.H., Vanderslice P.; RT "Structure, chromosomal assignment, and deduced amino acid sequence of a RT human gene for mast cell chymase."; RL J. Biol. Chem. 266:12956-12963(1991). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1). RC TISSUE=Heart; RX PubMed=1894611; DOI=10.1016/s0021-9258(19)47355-9; RA Urata H., Kinoshita A., Perez D.M., Misono K.S., Bumpus F.M., Graham R.M., RA Husain A.; RT "Cloning of the gene and cDNA for human heart chymase."; RL J. Biol. Chem. 266:17173-17179(1991). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 22-56; 123-132; RP 136-148; 167-194 AND 197-247, AND TISSUE SPECIFICITY. RC TISSUE=Skin; RX PubMed=8144971; RA Schechter N.M., Wang Z.M., Blacher R.W., Lessin S.R., Lazarus G.S., RA Rubin H.; RT "Determination of the primary structures of human skin chymase and RT cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions."; RL J. Immunol. 152:4062-4069(1994). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RX PubMed=19054851; DOI=10.1038/nmeth.1273; RA Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R., RA Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y., RA Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B., RA Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y., RA Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A., RA Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y., RA Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T., RA Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y., RA Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S., RA Nomura N.; RT "Human protein factory for converting the transcriptome into an in vitro- RT expressed proteome."; RL Nat. Methods 5:1011-1017(2008). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=12508121; DOI=10.1038/nature01348; RA Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C., RA Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A., RA Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H., RA Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T., RA Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B., RA Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D., RA Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R., RA Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S., RA Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C., RA Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S., RA Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., RA Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., RA Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M., RA Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V., RA Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J., RA Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F., RA Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F., RA Waterston R., Hood L., Weissenbach J.; RT "The DNA sequence and analysis of human chromosome 14."; RL Nature 421:601-607(2003). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT RP ARG-66. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] OF 22-247 (ISOFORM 1). RX PubMed=8495723; DOI=10.1016/0014-5793(93)81461-8; RA Sukenaga Y., Kido H., Neki A., Enomoto M., Ishida K., Takagi K., RA Katunuma N.; RT "Purification and molecular cloning of chymase from human tonsils."; RL FEBS Lett. 323:119-122(1993). RN [9] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-60. RC TISSUE=Placenta; RX PubMed=2049082; DOI=10.1042/bj2760567; RA Jenne D.E., Tschopp J.; RT "Angiotensin II-forming heart chymase is a mast-cell-specific enzyme."; RL Biochem. J. 276:567-568(1991). RN [10] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-80 AND ASN-103. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). RN [11] RP X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS). RX PubMed=9400368; DOI=10.1021/bi971403n; RA McGrath M.E., Mirzadegan T., Schmidt B.F.; RT "Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase RT at 1.9 A."; RL Biochemistry 36:14318-14324(1997). RN [12] RP X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS). RX PubMed=9931257; DOI=10.1006/jmbi.1998.2462; RA Pereira P.J.P., Wang Z.-M., Rubin H., Huber R., Bode W., Schechter N.M., RA Strobl S.; RT "The 2.2-A crystal structure of human chymase in complex with succinyl-Ala- RT Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl RT carboxypeptidase specificity."; RL J. Mol. Biol. 286:163-173(1999). RN [13] RP ERRATUM OF PUBMED:9931257. RX PubMed=10208809; DOI=10.1006/jmbi.1999.2691; RA Pereira P.J.P., Wang Z.-M., Rubin H., Huber R., Bode W., Schechter N.M., RA Strobl S.; RL J. Mol. Biol. 286:817-817(1999). CC -!- FUNCTION: Major secreted protease of mast cells with suspected roles in CC vasoactive peptide generation, extracellular matrix degradation, and CC regulation of gland secretion. CC -!- CATALYTIC ACTIVITY: CC Reaction=Preferential cleavage: Phe-|-Xaa > Tyr-|-Xaa > Trp-|-Xaa > CC Leu-|-Xaa.; EC=3.4.21.39; CC -!- SUBCELLULAR LOCATION: Secreted. Cytoplasmic granule. Note=Mast cell CC granules. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P23946-1; Sequence=Displayed; CC Name=2; CC IsoId=P23946-2; Sequence=VSP_056947; CC -!- TISSUE SPECIFICITY: Mast cells in lung, heart, skin and placenta. CC Expressed in both normal skin and in urticaria pigmentosa lesions. CC {ECO:0000269|PubMed:8144971}. CC -!- SIMILARITY: Belongs to the peptidase S1 family. Granzyme subfamily. CC {ECO:0000255|PROSITE-ProRule:PRU00274}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M64269; AAA52020.1; -; Genomic_DNA. DR EMBL; M69137; AAA52021.1; -; Genomic_DNA. DR EMBL; M69136; AAA52019.1; -; mRNA. DR EMBL; AB451464; BAG70278.1; -; mRNA. DR EMBL; AL132800; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471078; EAW66007.1; -; Genomic_DNA. DR EMBL; BC069110; AAH69110.1; -; mRNA. DR EMBL; BC069370; AAH69370.1; -; mRNA. DR EMBL; BC069490; AAH69490.1; -; mRNA. DR EMBL; BC103974; AAI03975.1; -; mRNA. DR EMBL; BC103975; AAI03976.1; -; mRNA. DR EMBL; S61334; AAB26828.1; -; mRNA. DR EMBL; X59072; CAA41796.1; -; Genomic_DNA. DR CCDS; CCDS76666.1; -. [P23946-2] DR CCDS; CCDS9630.1; -. [P23946-1] DR PIR; A40967; KYHUCM. DR RefSeq; NP_001295012.1; NM_001308083.1. [P23946-2] DR RefSeq; NP_001827.1; NM_001836.4. [P23946-1] DR PDB; 1KLT; X-ray; 1.90 A; A=22-247. DR PDB; 1NN6; X-ray; 1.75 A; A=20-247. DR PDB; 1PJP; X-ray; 2.20 A; A=22-247. DR PDB; 1T31; X-ray; 1.90 A; A=22-247. DR PDB; 2HVX; X-ray; 2.60 A; A=22-247. DR PDB; 3N7O; X-ray; 1.80 A; A=22-247. DR PDB; 3S0N; X-ray; 1.95 A; A=22-247. DR PDB; 4AFQ; X-ray; 1.51 A; A/B=22-247. DR PDB; 4AFS; X-ray; 1.90 A; A=22-247. DR PDB; 4AFU; X-ray; 1.82 A; A/B=22-247. DR PDB; 4AFZ; X-ray; 2.25 A; A/B=22-247. DR PDB; 4AG1; X-ray; 1.40 A; A=22-247. DR PDB; 4AG2; X-ray; 1.80 A; A/B=22-247. DR PDB; 4K2Y; X-ray; 2.30 A; A=22-247. DR PDB; 4K5Z; X-ray; 1.80 A; A=22-247. DR PDB; 4K60; X-ray; 1.50 A; A=22-247. DR PDB; 4K69; X-ray; 1.50 A; A=22-247. DR PDB; 4KP0; X-ray; 2.80 A; A=22-247. DR PDB; 5YJM; X-ray; 1.90 A; A=22-247. DR PDB; 5YJP; X-ray; 1.80 A; A=22-247. DR PDBsum; 1KLT; -. DR PDBsum; 1NN6; -. DR PDBsum; 1PJP; -. DR PDBsum; 1T31; -. DR PDBsum; 2HVX; -. DR PDBsum; 3N7O; -. DR PDBsum; 3S0N; -. DR PDBsum; 4AFQ; -. DR PDBsum; 4AFS; -. DR PDBsum; 4AFU; -. DR PDBsum; 4AFZ; -. DR PDBsum; 4AG1; -. DR PDBsum; 4AG2; -. DR PDBsum; 4K2Y; -. DR PDBsum; 4K5Z; -. DR PDBsum; 4K60; -. DR PDBsum; 4K69; -. DR PDBsum; 4KP0; -. DR PDBsum; 5YJM; -. DR PDBsum; 5YJP; -. DR AlphaFoldDB; P23946; -. DR SMR; P23946; -. DR BioGRID; 107624; 63. DR IntAct; P23946; 1. DR STRING; 9606.ENSP00000250378; -. DR BindingDB; P23946; -. DR ChEMBL; CHEMBL4068; -. DR DrugBank; DB03814; 2-(N-morpholino)ethanesulfonic acid. DR DrugBank; DB04016; 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid. DR DrugBank; DB07680; [(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID. DR DrugBank; DB03297; Benzylsulfonic acid. DR DrugCentral; P23946; -. DR GuidetoPHARMACOLOGY; 2340; -. DR MEROPS; S01.140; -. DR GlyCosmos; P23946; 2 sites, No reported glycans. DR GlyGen; P23946; 2 sites. DR iPTMnet; P23946; -. DR PhosphoSitePlus; P23946; -. DR BioMuta; CMA1; -. DR DMDM; 126825; -. DR jPOST; P23946; -. DR MassIVE; P23946; -. DR PaxDb; 9606-ENSP00000250378; -. DR PeptideAtlas; P23946; -. DR ProteomicsDB; 54171; -. [P23946-1] DR Antibodypedia; 3125; 459 antibodies from 39 providers. DR DNASU; 1215; -. DR Ensembl; ENST00000206446.4; ENSP00000206446.4; ENSG00000092009.10. [P23946-2] DR Ensembl; ENST00000250378.7; ENSP00000250378.3; ENSG00000092009.10. [P23946-1] DR GeneID; 1215; -. DR KEGG; hsa:1215; -. DR MANE-Select; ENST00000250378.7; ENSP00000250378.3; NM_001836.5; NP_001827.1. DR UCSC; uc001wpp.2; human. [P23946-1] DR AGR; HGNC:2097; -. DR CTD; 1215; -. DR DisGeNET; 1215; -. DR GeneCards; CMA1; -. DR HGNC; HGNC:2097; CMA1. DR HPA; ENSG00000092009; Tissue enhanced (breast). DR MIM; 118938; gene. DR neXtProt; NX_P23946; -. DR OpenTargets; ENSG00000092009; -. DR PharmGKB; PA26623; -. DR VEuPathDB; HostDB:ENSG00000092009; -. DR eggNOG; KOG3627; Eukaryota. DR GeneTree; ENSGT01030000234551; -. DR HOGENOM; CLU_006842_1_0_1; -. DR InParanoid; P23946; -. DR OMA; MDPQACR; -. DR OrthoDB; 2540265at2759; -. DR PhylomeDB; P23946; -. DR TreeFam; TF333630; -. DR BRENDA; 3.4.21.39; 2681. DR PathwayCommons; P23946; -. DR Reactome; R-HSA-1433557; Signaling by SCF-KIT. DR Reactome; R-HSA-1592389; Activation of Matrix Metalloproteinases. DR Reactome; R-HSA-2022377; Metabolism of Angiotensinogen to Angiotensins. DR SABIO-RK; P23946; -. DR SignaLink; P23946; -. DR SIGNOR; P23946; -. DR BioGRID-ORCS; 1215; 11 hits in 1148 CRISPR screens. DR EvolutionaryTrace; P23946; -. DR GeneWiki; CMA1; -. DR GenomeRNAi; 1215; -. DR Pharos; P23946; Tchem. DR PRO; PR:P23946; -. DR Proteomes; UP000005640; Chromosome 14. DR RNAct; P23946; Protein. DR Bgee; ENSG00000092009; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 96 other cell types or tissues. DR GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0005576; C:extracellular region; HDA:BHF-UCL. DR GO; GO:0005615; C:extracellular space; IBA:GO_Central. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central. DR GO; GO:0030141; C:secretory granule; IDA:MGI. DR GO; GO:0004175; F:endopeptidase activity; EXP:Reactome. DR GO; GO:0042277; F:peptide binding; IEA:Ensembl. DR GO; GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL. DR GO; GO:0008236; F:serine-type peptidase activity; EXP:Reactome. DR GO; GO:0002003; P:angiotensin maturation; TAS:Reactome. DR GO; GO:0034769; P:basement membrane disassembly; IDA:BHF-UCL. DR GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl. DR GO; GO:0140447; P:cytokine precursor processing; IDA:BHF-UCL. DR GO; GO:0022617; P:extracellular matrix disassembly; IDA:BHF-UCL. DR GO; GO:0030901; P:midbrain development; IEA:Ensembl. DR GO; GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl. DR GO; GO:0030163; P:protein catabolic process; IEA:Ensembl. DR GO; GO:0050727; P:regulation of inflammatory response; IDA:BHF-UCL. DR CDD; cd00190; Tryp_SPc; 1. DR Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2. DR InterPro; IPR009003; Peptidase_S1_PA. DR InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin. DR InterPro; IPR001314; Peptidase_S1A. DR InterPro; IPR001254; Trypsin_dom. DR InterPro; IPR018114; TRYPSIN_HIS. DR InterPro; IPR033116; TRYPSIN_SER. DR PANTHER; PTHR24271:SF24; CHYMASE; 1. DR PANTHER; PTHR24271; KALLIKREIN-RELATED; 1. DR Pfam; PF00089; Trypsin; 1. DR PRINTS; PR00722; CHYMOTRYPSIN. DR SMART; SM00020; Tryp_SPc; 1. DR SUPFAM; SSF50494; Trypsin-like serine proteases; 1. DR PROSITE; PS50240; TRYPSIN_DOM; 1. DR PROSITE; PS00134; TRYPSIN_HIS; 1. DR PROSITE; PS00135; TRYPSIN_SER; 1. DR Genevisible; P23946; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Direct protein sequencing; KW Disulfide bond; Glycoprotein; Hydrolase; Protease; Reference proteome; KW Secreted; Serine protease; Signal; Zymogen. FT SIGNAL 1..19 FT PROPEP 20..21 FT /note="Activation peptide" FT /evidence="ECO:0000269|PubMed:8144971" FT /id="PRO_0000027433" FT CHAIN 22..247 FT /note="Chymase" FT /id="PRO_0000027434" FT DOMAIN 22..245 FT /note="Peptidase S1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00274" FT ACT_SITE 66 FT /note="Charge relay system" FT ACT_SITE 110 FT /note="Charge relay system" FT ACT_SITE 203 FT /note="Charge relay system" FT CARBOHYD 80 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218, FT ECO:0000269|PubMed:2071582" FT CARBOHYD 103 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218" FT DISULFID 51..67 FT DISULFID 144..209 FT DISULFID 175..188 FT VAR_SEQ 1..111 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_056947" FT VARIANT 46 FT /note="G -> R (in dbSNP:rs5246)" FT /id="VAR_011770" FT VARIANT 66 FT /note="H -> R (in dbSNP:rs5247)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_011771" FT VARIANT 98 FT /note="R -> H (in dbSNP:rs13306252)" FT /id="VAR_029190" FT CONFLICT 28 FT /note="C -> S (in Ref. 8; AAB26828)" FT /evidence="ECO:0000305" FT CONFLICT 131..132 FT /note="FP -> AV (in Ref. 3; AA sequence)" FT /evidence="ECO:0000305" FT STRAND 36..42 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 44..47 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 49..57 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 60..63 FT /evidence="ECO:0007829|PDB:4AG1" FT HELIX 65..67 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 70..77 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 79..83 FT /evidence="ECO:0007829|PDB:4AFU" FT STRAND 89..98 FT /evidence="ECO:0007829|PDB:4AG1" FT TURN 104..106 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 112..118 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 124..126 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 143..153 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 163..170 FT /evidence="ECO:0007829|PDB:4AG1" FT HELIX 172..175 FT /evidence="ECO:0007829|PDB:4AG1" FT TURN 183..185 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 186..190 FT /evidence="ECO:0007829|PDB:4AG1" FT TURN 192..194 FT /evidence="ECO:0007829|PDB:1NN6" FT STRAND 206..209 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 212..219 FT /evidence="ECO:0007829|PDB:4AG1" FT STRAND 228..232 FT /evidence="ECO:0007829|PDB:4AG1" FT HELIX 233..246 FT /evidence="ECO:0007829|PDB:4AG1" SQ SEQUENCE 247 AA; 27325 MW; DC1464A049ED6B00 CRC64; MLLLPLPLLL FLLCSRAEAG EIIGGTECKP HSRPYMAYLE IVTSNGPSKF CGGFLIRRNF VLTAAHCAGR SITVTLGAHN ITEEEDTWQK LEVIKQFRHP KYNTSTLHHD IMLLKLKEKA SLTLAVGTLP FPSQFNFVPP GRMCRVAGWG RTGVLKPGSD TLQEVKLRLM DPQACSHFRD FDHNLQLCVG NPRKTKSAFK GDSGGPLLCA GVAQGIVSYG RSDAKPPAVF TRISHYRPWI NQILQAN //